Moderna Corona vaccine has 94% efficacy, final status confirmed | Moderna claims, confirmed in latest trial, our corona vaccine 94% effective

New Delhi: An increase is once again seen in Corona cases around the world. But it’s also a matter of relief that many companies have claimed to manufacture the Corona vaccine. In this regard, after the world’s leading pharmaceutical companies Sputnik and Pfizer, another company has claimed success in manufacturing effective drugs against Corona. US company Mordana said its vaccine, which protects against corona, was up to 94% effective in its last trial.

Awaiting US Department Approval
The American company Moderna is now in the final stages of sending a report of the results of the latest trial of its vaccine to government regulators in the United States (USA), Europe and the United Kingdom (United Kingdom) for emergency licenses. The company said it hopes the Food and Drug Administration of America can approve the use of its vaccine at its December 17 meeting.

Supply in Great Britain possible after March
According to Mordana, his vaccine in Britain was 94.5 percent effective in the last phase. Encouraged by last week’s results, the company said its supply would not be possible in the UK until March 2021. Mordana has received US $ 2.48 billion in funds from the US federal government to manufacture the vaccine.

Also Read- RT-PCTR test price reduced in Delhi, not 2400 now, Corona will be tested in this

3 companies work in India
In India, too, work is underway to make the corona vaccine faster. Prime Minister Narendra Modi (Narendra Modi) reviewed vaccine preparations at Zydus Biotech Park in Ahmedabad, Bharat Bioteck in Hyderabad and the Serum Institute in Pune. It is believed that there will be good news about the Corona vaccine soon.

According to the Serum Institute of India, its corona vaccine will soon be ready for use. The company says the results of its “KoviShield” trial were excellent. Company executives said a request would be made for permission to use Kovishield in an emergency. At the same time, the human trial of the Russian Corona Sputnik V vaccine was approved in India. The Comptroller General of Medicines of India (DCGI) keeps an eye on all information relating to the development of the Corona vaccine in the country.